The fourth gene deregulated in TFCP2-rearranged sarcoma, besides ALK, CDKN2A, and MTAP, is TERT, encoding the catalytic component of the telomerase complex that protects dividing cells from progressive telomere shortening, subsequent senescence, and malignant transformation52. Here, TERT is linked to sarcoma.